Veracyte (VCYT) Tops Q2 EPS by 33c, provides guidance

Veracyte (NASDAQ: VCYT) reported Q2 EPS of $0.44, $0.33 better than the analyst estimate of $0.11. Revenue for the quarter came in at $130.16 million versus the consensus estimate of $121.1 million.

GUIDANCE:

Veracyte sees FY2025 revenue of $496-504 million, versus the consensus of $491.9 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.

You May Also Be Interested In

• Goldman Sachs Upgrades China Resources Microelectronics Ltd (688396:CH) to Neutral
• Jefferies Downgrades Belimo Holding AG (BEAN:SW) (BLHWF) to Hold
• Berenberg Downgrades Umicore SA (UMI:BB) (UMICY) to Hold